ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2015

Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer.

Victoria Hillerdal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.